Direct and indirect costs of asthma in Canada, 1990.
Direct and indirect costs of asthma in Canada, 1990.
复制标题
加拿大哮喘的直接和间接成本,1990 年。
DOI:
--
复制
发表时间:
1996
期刊:
影响因子:
--
通讯作者:
Allan S. Detsky
中科院分区:
文献类型:
--
作者:
Murray Krahn;C. Berka;P. Langlois;Allan S. Detsky
OBJECTIVE
To calculate the direct and indirect costs of asthma in Canada.
DESIGN
Cost-of-illness study.
SETTING
Canada.
PATIENTS
All Canadians receiving inpatient or outpatient care for asthma in 1990.
OUTCOME MEASURES
Direct costs incurred by inpatient care, emergency services, physician and nursing services, ambulance use, drugs and devices, outpatient diagnostic tests, research and education. Indirect costs from productivity loss due to absence from work, inability to to perform housekeeping activities, need to care for children with asthma who were absent from school, time spent travelling and waiting for medical care, and premature death from asthma. All costs are in 1990 Canadian dollars.
RESULTS
Depending on assumptions, the total cost of asthma was estimated to be between $504 million and $648 million. Direct costs were $306 million. The single largest component of direct costs was the cost of drugs ($124 million). The largest component of indirect costs was illness-related disability ($76 million).
CONCLUSIONS
Annual costs of treating asthma are comparable to the individual cost of infectious diseases, hematological diseases, congenital defects, perinatal illnesses, home care and ambulance services. Asthma costs may increase in the future, given current morbidity and mortality trends. Further evaluation of the effectiveness and cost-effectiveness of available asthma interventions in addition to aggregate cost data are required to determine whether resource allocation for the treatment of asthma can be improved.
影响因子:
12.7
作者:
Windsor,RA;Bailey,WC;RichardsJr,JM;Manzella,B;Soong,SJ;Brooks,M
通讯作者:
Brooks,M